Krs Capital Management, LLC Dexcom Inc Transaction History

Krs Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$110.31 - $140.45 $79,643 - $101,404	722 Added 26.94%	3,402 $385,000
Q1 2024 Apr 16, 2024	BUY	$114.22 - $140.1 $31,981 - $39,228	280 Added 11.67%	2,680 $371,000
Q4 2022 Jan 19, 2023	BUY	$84.98 - $122.67 $203,952 - $294,408	2,400 New	2,400 $0
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $40,794 - $79,733	-600 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $77,922 - $97,692	600 New	600 $322,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krs Capital Management, LLC with notifications on news.